Table 2

Levels of Evidence for Primary Research Question.

Types of Studies
Therapeutic Studies Investigating the Results of TreatmentPrognostic Studies Investigating the Outcome of DiseaseDiagnostic Studies Investigating a Diagnostic TestEconomic and Decision Analyses Developing an Economic or Decision Model
Level I1. Randomized controlled trial
a. Significant difference
b. No significant difference but narrow confidence intervals
2. Systematic review2 of Level-I randomized controlled trials (studies were homogeneous)
1. Prospective study1
2. Systematic review2 of Level-I studies
1. Testing of previously developed diagnostic criteria in series of consecutive patients (with universally applied reference “gold” standard)
2. Systematic review2 of Level-I studies
1. Clinically sensible costs and alternatives; values obtained from many studies; multiway sensitivity analyses
2. Systematic review2 of Level-I studies
Level II1. Prospective cohort study3
2. Poor-quality randomized controlled trial (e.g., <80% follow-up)
3. Systematic review2
a. Level-II studies
b. nonhomogeneous Level-I studies
1. Retrospective study4
2. Study of untreated controls from a previous randomized controlled trial
3. Systematic review of Level-II studies
1. Development of diagnostic criteria on basis of consective patients (with universally applied reference “gold” standard)
2. Systematic review2 of Level-II studies
1. Clinically sensible costs and alternatives; values obtained from many studies; multiway sensitivity analyses
2. Systematic review2 of Level-II studies
Level III1. Case-control study5
2. Retrospective cohort study4
3. Systematic review2 of Level-III studies
1. Study of non-consecutive patients (no consistently applied reference “gold” standard)
2. Systematic review2 of Level-III studies
1. Limited alternatives and costs; poor estimates
2. Systematic review2 of Level-III studies
Level IVCase series (no, or historical, control group)Case series1. Case-control study
2. Poor reference standard
No sensitivity analyses
Level VExpert opinionExpert opinionExpert opinionExpert opinion
1. All patients were enrolled at the same point in their disease course (inception cohort) with ≥80% follow-up of enrolled patients.
2. A study of results from two or more previous studies.
3. Patients were compared with a control group of patients treated at the same time and institution.
4. The study was initiated after treatment was performed.
5. Patients with a particular outcome (“cases” with, for example, a failed total arthroplasty) were compared with those who did not have the outcome (“controls” with, for example, a total hip arthroplasty that did not fail).